Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: Evidence for the development of tolerance to selective serotonin re-uptake inhibitor

Saved in:
Bibliographic Details
Published in:Biological psychiatry (1969) 1996-07, Vol.40 (1), p.75-77
Main Authors: Silver, Henry, Barash, Igor, Odnopozov, Natan, Jahjah, Najib, Mizruhin, Alex
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Biomarkers
Chronic Disease
Dose-Response Relationship, Drug
Drug Tolerance
Female
fluvoxamine
Fluvoxamine - therapeutic use
Humans
Male
Medical sciences
Melatonin
Melatonin - blood
negative symptoms
Neuropharmacology
Pharmacology. Drug treatments
Psychiatric Status Rating Scales
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
schizophrenia
Schizophrenia - blood
Schizophrenia - drug therapy
Serotonin Uptake Inhibitors - therapeutic use
SSRI-augmentation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-3223
1873-2402
DOI:10.1016/0006-3223(95)00431-9